User profiles for K. Kanigel Winner

Kimberly Kanigel Winner

Scientist, Rancho Biosciences
Verified email at unm.edu
Cited by 306

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge …

…, Z Ji, D Juvvadi, S Jyrkkiö, K Kanigel-Winner… - The Lancet …, 2017 - thelancet.com
Background Improvements to prognostic models in metastatic castration-resistant prostate
cancer have the potential to augment clinical trial design and guide treatment strategies. In …

A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer

…, L Kumar, RD Wolfinger, K Kanigel Winner… - JCO clinical cancer …, 2017 - ascopubs.org
Purpose Docetaxel has a demonstrated survival benefit for patients with metastatic
castration-resistant prostate cancer (mCRPC); however, 10% to 20% of patients discontinue …

[HTML][HTML] Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical …

MP Steinkamp, KK Winner, S Davies, C Muller… - Frontiers in …, 2013 - frontiersin.org
Ovarian cancer relapse is often characterized by metastatic spread throughout the peritoneal
cavity with tumors attached to multiple organs. In this study, interaction of ovarian cancer …

Spatial modeling of drug delivery routes for treatment of disseminated ovarian cancer

KRK Winner, MP Steinkamp, RJ Lee, M Swat… - Cancer research, 2016 - AACR
In ovarian cancer, metastasis is typically confined to the peritoneum. Surgical removal of the
primary tumor and macroscopic secondary tumors is a common practice, but more effective …

A Spatiotemporal Model to Simulate Chemotherapy Regimens for Heterogeneous Bladder Cancer Metastases to the Lung

KR KANIGEL WINNER, JC Costello - PACIFIC SYMPOSIUM ON …, 2017 - World Scientific
… For more explicit descriptions of the cellular Potts model for modeling drug delivery in
tumors, please see Kanigel Winner, et al.,33 and Extended Methods are available at https://…

Multi-scale models of ovarian cancer

KR Kanigel Winner - 2015 - digitalrepository.unm.edu
… My mother, Vivian Kay Kanigel, cared for my son for 7 months before my defense; my
sister and brother-in-law, Kara and Trent Copanas, have welcomed us into their home as we …

[PDF][PDF] Ovarian cancer relapse: micro-carcinomas vary in form with peritoneal niche

K Kanigel-Winner, M Steinkamp, S Davies… - 8th Student …, 2012 - researchgate.net
Short Abstract—In ovarian cancer, the morphology of microscopic tumors depends on local
characteristics of tissues to which cells initially attach in the peritoneal cavity. We use an …

A community-based collaboration to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer

…, E Gofer, L Kumar, RD Wolfinger, K Kanigel Winner… - bioRxiv, 2016 - biorxiv.org
Background Docetaxel has a demonstrated survival benefit for metastatic castration-resistant
prostate cancer (mCRPC). However, 10-20% of patients discontinue docetaxel prematurely …

Implementation of the FAIR data principles for exploratory biomarker data from clinical trials

…, D Das, C Farhy, R Ferguson, H Huang, K Kanigel… - Data …, 2021 - direct.mit.edu
The FAIR data guiding principles have been recently developed and widely adopted to improve
the Findability, Accessibility, Interoperability, and Reuse of digital assets in the face of an …

[BOOK][B] Multi-scale models of ovarian cancer

KK Winner - 2015 - search.proquest.com
Kimberly Rene Kanigel Winner Biology This dissertation is approved, and it is acceptable in …
My mother, Vivian Kay Kanigel, cared for my son for 7 months before my defense; my sister …